Clinical trials are moving toward faster data, faster signals, and faster decisions. The FDA recently announced real-time clinical trial proof-of-concepts and a proposed pilot program designed to help trial endpoints and data signals move to the agency in real time. The agency also opened a Request for Information, with comments due by May 29, 2026. That’s a major shift for clinical development. But it also raises an important question: Can patient recruitment keep up?